PMTs develop in transgenic mice due to elevated expression of the type I insulin-like growth factor receptor (IGF-IR) and these tumors have an epithelial appearance but cluster most closely with human basal-like breast cancers [39, 41, 42]. This evidence concerns the gene IGF1R and breast cancer.